Replimune Group (REPL) News Today

Acadian Asset Management LLC bought a new position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 113,649 shares of the company's stock, valued at approxi

BNP Paribas Financial Markets lessened its stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 70.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 58,725 shares of the company's stock after sel

Replimune Group (NASDAQ:REPL) Shares Down 5.6%

Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) was the recipient of a large decline in short interest in the month of June. As of June 30th, there was short interest totalling 5,740,000 shares, a decline of 38.9% from the June 15th total of 9,390,000 shares. Based on an average trading volume of 1,180,000 shares, the short-interest ratio is currently 4.9 days. Approximately 12.7% of the company's shares are short sold.

Replimune Group (NASDAQ:REPL) Trading 10.9% Higher

Replimune Group (NASDAQ:REPL) Shares Down 3.4%

Replimune Group (NASDAQ:REPL) Stock Price Up 4.9%

Goldman Sachs Group Inc. increased its stake in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 300.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,238,883 shares of the company's stock after purcha

Replimune Group (NASDAQ:REPL) Stock Price Up 3.7%

Replimune Group (NASDAQ:REPL) Trading Down 6%

Replimune Group (NASDAQ:REPL) Shares Gap Up to $8.82

Replimune Group (NASDAQ:REPL) Shares Gap Down on Insider Selling

Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) insider Konstantinos Xynos sold 15,881 shares of the stock in a transaction on Friday, June 7th. The shares were sold at an average price of $7.50, for a total value of $119,107.50. Following the completion of the sale, the insider now owns 117,131 shares of the company's stock, valued at $878,482.50. The sale was disclosed in a filing with the SEC, which is available at this link.

Replimune Group (NASDAQ:REPL) Shares Up 4.1% on Analyst Upgrade

Rafferty Asset Management LLC lifted its position in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 148.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 463,397 shares of the company's st

Barclays raised their target price on shares of Replimune Group from $13.00 to $17.00 and gave the company an "overweight" rating in a research report on Friday.

Wedbush reissued an "outperform" rating and issued a $16.00 price target on shares of Replimune Group in a research note on Thursday.

BNP Paribas Financial Markets increased its stake in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 517.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 196,251 shares of the company's stock af

Clearbridge Investments LLC purchased a new stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 270,695 shares of the company's stock, valued at approximately $2,282,000. Clea

Replimune Group, Inc. (NASDAQ:REPL - Get Free Report) insider Christopher Sarchi sold 2,218 shares of Replimune Group stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $6.47, for a total value of $14,350.46. Following the transaction, the insider now owns 92,252 shares of the company's stock, valued at $596,870.44. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Replimune Group, Inc. (NASDAQ:REPL - Free Report) - Wedbush issued their Q1 2026 earnings estimates for Replimune Group in a research note issued to investors on Thursday, May 16th. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.91) per share for the quarter. T

Vontobel Holding Ltd. bought a new position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 305,412 shares of the company's stock, valued at approximately $2,575,000. Vontobel Hold

Vanguard Group Inc. grew its position in Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 10.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 2,596,119 shares of the company's stock after buying an additional 242,220 shares during the period. Vanguard

Replimune Group (NASDAQ:REPL) Trading 5.3% Higher

Redmile Group LLC lowered its stake in shares of Replimune Group, Inc. (NASDAQ:REPL - Free Report) by 5.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,163,922 shares of the company's stock after selling

Replimune Group, Inc. (NASDAQ:REPL - Free Report) - Stock analysts at HC Wainwright raised their FY2024 earnings estimates for shares of Replimune Group in a research report issued to clients and investors on Thursday, February 15th. HC Wainwright analyst R. Burns now forecasts that the company w